Abstract
Tuberculous meningitis (TBM) disproportionally affects people in low- and middle-income countries and is
associated with high morbidity and mortality. Stroke is a common complication in TBM and can lead to severe
irreversible neurological disability. Studies on TBM-associated stroke pathology, however, have focused
primarily on HIV-uninfected individuals. The overall objective of this proposal is to use transcranial doppler and
brain imaging to understand changes in cerebral blood vessels and cerebral blood flow in order to determine
changes in cerebrovascular responsiveness, characterize patterns of stroke, and describe long-term
neurocognitive outcomes in HIV-associated TBM. The central hypothesis is that in HIV-infected individuals,
TBM causes extensive cerebral vascular narrowing and impaired cerebrovascular responsiveness, decreased
cerebral blood flow, and ultimately stroke. The central hypothesis will be tested by pursuing three specific aims:
1) describe changes in cerebrovascular responsiveness in HIV-associated TBM; 2) characterize the patterns of
stroke in HIV-associated TBM and determine whether it is associated with vasculopathy and/or impairments in
cerebrovascular responsiveness; and 3) determine if impaired cerebrovascular responsiveness predicts long-
term neurological outcome in HIV-associated TBM. Under Aim 1, transcranial doppler will be used to take
repeated measurements of the middle cerebral artery flow velocity and pulsatility index. A subset of study
subjects will also have dynamic measurements made in response to stimuli (inhaled CO2, changes in blood
pressure, and motor tasks). We will determine whether cerebrovascular responsiveness is impaired in HIV-
associated TBM by comparing measurements to those of control patients with no neurological infection. Under
Aim 2, all study subjects will have a brain MRI performed within the first 2-weeks of TBM treatment to identify
the presence of a cerebral artery stroke and the associated cerebral artery territory. We will compare TCD
readings between participants with or without stroke. Under Aim 3, we will examine how TCD measurements at
study enrolment relate to the results of neurocognitive testing at month 2 and functional assessment at month
6. Ultimately, the long-term goal of the proposal is to describe how impaired cerebrovascular responsiveness in
HIV-associated TBM contributes to the development of strokes and resulting neurocognitive impairment and
disability. The research proposed in this application is innovative because it incorporates the use of
transcranial doppler at the bedside, to be used in real time, in the care of subjects with TBM. The proposed
research is significant because it is expected to provide strong scientific justification for the development of
future clinical trials testing targeted interventions to improve cerebrovascular responsiveness and prevent the
development of strokes in HIV-associated TBM. Ultimately, such knowledge has the potential of preventing the
development of irreversible neurological injury and improving both short and long-term outcomes.
Public Health Relevance Statement
Project Narrative
The proposed research is relevant to public health because it focuses on understanding the pathophysiological
changes to cerebral vessels in HIV-associated tuberculous meningitis so as to understand the mechanism
underlying stroke development and long-term neurological disability. Once the mechanism leading to strokes in
TBM is understood, there is the protentional for the development of targeted interventions to reduce the
incidence of strokes in HIV-associated tuberculous meningitis. Thus, the proposed research is relevant to
NINDS’ mission pertaining to the reduction of long-term neurological disability in neuroinfections.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AffectAgeBasal GangliaBlood Flow VelocityBlood PressureBlood VesselsBlood flowBrain imagingCarbon DioxideCaringCategoriesCentral Nervous System InfectionsCephalicCerebral InfarctionCerebrovascular CirculationCerebrovascular PhysiologyCerebrovascular systemCerebrumClinicalClinical TrialsCollaborationsCommunicable DiseasesComplicationDeath RateDevelopmentDiseaseEnrollmentFunctional disorderFutureGoalsHIVHIV InfectionsImageImmune responseImpairmentIndividualInfectionInhalationInterventionKnowledgeMagnetic Resonance ImagingMeasurementMeasuresMeningeal TuberculosisMeningitisMinnesotaMissionMorbidity - disease rateMotorNational Institute of Neurological Disorders and StrokeNecrosisNervous System DisorderNervous System TraumaNeurocognitiveNeurocognitive DeficitNeurologicNeurological disabilityNeurological outcomeOutcomeOutcome AssessmentParticipantPathogenesisPathologyPatientsPatternPerforating ArteryPerformancePersonsPhaseProductivityProspective, cohort studyPublic HealthResearchStimulusStrokeStudy SubjectSurvivorsTestingTimeTranscranial Doppler UltrasonographyUgandaUniversitiesVascular Diseasesbrain magnetic resonance imagingcerebral arterycerebral hemodynamicscerebrovasculardisabilityexperiencefollow-upfunctional outcomesimprovedindexinginnovationlow and middle-income countriesmiddle cerebral arterymortalityneurocognitive testnovelpredicting responsepreventrandomized, clinical trialsresponsestroke incidencetheories
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
555917996
UEI
KABJZBBJ4B54
Project Start Date
01-August-2023
Project End Date
31-July-2025
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$125,253
Direct Costs
$105,865
Indirect Costs
$19,388
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$125,253
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21NS134516-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21NS134516-02
Patents
No Patents information available for 5R21NS134516-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21NS134516-02
Clinical Studies
No Clinical Studies information available for 5R21NS134516-02
News and More
Related News Releases
No news release information available for 5R21NS134516-02
History
No Historical information available for 5R21NS134516-02
Similar Projects
No Similar Projects information available for 5R21NS134516-02